Received Aug 15, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | Y019318 | OT |
HCP reporting that a patient received a dose of improperly stored VARIVAX. Reference TE case #02843001. HCP reported that she did not know the date the excursion occurred, but knows the VARIVAX was administered following the excursion. HCP reported; No symptoms or side effects were reported by HCP; This spontaneous report was received from a Nurse and refers to a patient of unknown age and gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 10-JUL-2025, the patient was vaccinated with an improperly stored dose of Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX), Injection, lot #Y019318, expiration date reported as 21-NOV-2026, 0.5 mL (route of administration and anatomical location of vaccine were not reported) diluted with sterile diluent (MERCK STERILE DILUENT) (lot # and expiration date were not reported); as treatment for prophylaxis. The dose experienced a temperature excursion of 52.2 Fahrenheit for an unspecified time frame. No additional adverse event were repoted.
sterile diluent